X-ZELL officially incorporated in Singapore Singapore, October 2018 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, is coming to Singapore. According to X-ZELL CEO, Dr Sebastian Bhakdi, the rare cell detection specialist’s global...
X-ZELL among Asia's 20 most innovative health-tech start-ups Singapore, September 2018 – Galen Growth, a Singapore-based analytics and advisory firm specialising in cutting-edge healthcare technology, has named X-ZELL as one of the 20 most innovative health technology...
Ground-breaking X-ZELL research featured in BJU International Oxford, August 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has published new research into the utility of tumour-associated Circulating Endothelial Cells (tCEC) for the detection of early-stage prostate cancer....
